Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
J Chem Inf Model ; 62(24): 6316-6322, 2022 12 26.
Article in English | MEDLINE | ID: mdl-35946899

ABSTRACT

The Molecular Education and Research Consortium in Undergraduate Computational Chemistry (MERCURY) has supported a diverse group of faculty and students for over 20 years by providing computational resources as well as networking opportunities and professional support. The consortium comprises 38 faculty (42% women) at 34 different institutions, who have trained nearly 900 undergraduate students, more than two-thirds of whom identify as women and one-quarter identify as students of color. MERCURY provides a model for the support necessary for faculty to achieve professional advancement and career satisfaction. The range of experiences and expertise of the consortium members provides excellent networking opportunities that allow MERCURY faculty to support each other's teaching, research, and service needs, including generating meaningful scientific advancements and outcomes with undergraduate researchers as well as being leaders at the departmental, institutional, and national levels. While all MERCURY faculty benefit from these supports, the disproportionate number of women in the consortium, relative to their representation in computational sciences generally, produces a sizable impact on advancing women in the computational sciences. In this report, the women of MERCURY share how the consortium has benefited their careers and the careers of their students.


Subject(s)
Computational Chemistry , Students , Humans , Female , Male , Faculty , Research Personnel
2.
R Soc Open Sci ; 5(3): 172193, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29657812

ABSTRACT

Understanding how populations adapt to rising temperatures has been a challenge in ecology. Research often evaluates multiple populations to test whether local adaptation to temperature regimes is occurring. Space-for-time substitutions are common, as temporal constraints limit our ability to observe evolutionary responses. We employed a resurrection ecology approach to understand how thermal tolerance has changed in a Daphnia pulicaria population over time. Temperatures experienced by the oldest genotypes were considerably lower than the youngest. We hypothesized clones were adapted to the thermal regimes of their respective time periods. We performed two thermal shock experiments that varied in length of heat exposure. Overall trends revealed that younger genotypes exhibited higher thermal tolerance than older genotypes; heat shock protein (hsp70) expression increased with temperature and varied among genotypes, but not across time periods. Our results indicate temperature may have been a selective factor on this population, although the observed responses may be a function of multifarious selection. Prior work found striking changes in population genetic structure, and in other traits that were strongly correlated with anthropogenic changes. Resurrection ecology approaches should help our understanding of interactive effects of anthropogenic alterations to temperature and other stressors on the evolutionary fate of natural populations.

3.
G Ital Cardiol ; 29(2): 152-4, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10088071

ABSTRACT

A case of 28-year-old woman with Ebstein's anomaly and complete AV block, requiring a permanent dual-chamber pacemaker implantation, is described. The ventricular lead was successfully placed in the right ventricular outflow tract and there was no problem associated with positioning of the atrial electrode in the right atrial appendage, with good sensing and threshold. The subsequent clinical course was uncomplicated and the patient has remained asymptomatic throughout the eight-month follow-up. This experience allows us to state that even in the presence of the marked structural abnormalities of Ebstein's anomaly, dual-chamber pacing is indeed feasible and successful, enabling the disappearance of symptoms related to the AV block.


Subject(s)
Ebstein Anomaly/therapy , Pacemaker, Artificial , Adult , Ebstein Anomaly/diagnosis , Echocardiography , Electrocardiography , Electrocardiography, Ambulatory , Female , Humans
4.
Circulation ; 96(12): 4314-8, 1997 Dec 16.
Article in English | MEDLINE | ID: mdl-9416898

ABSTRACT

BACKGROUND: Nonuniform recovery of ventricular excitability has been demonstrated to facilitate the reentry circuits leading to the development of ventricular tachyarrhythmias. This can also occur in arrhythmogenic right ventricular dysplasia (ARVD). In fact, in patients with ARVD, abnormalities of ventricular repolarization are often observed on 12-lead ECGs, but their predictive value for the occurrence of malignant arrhythmias is yet to be established. Because body-surface potential mapping has been proved to be useful for the detection of heterogeneities in ventricular recovery even though they are not revealed by conventional 12-lead ECGs, we attempted to analyze repolarization potentials on the entire chest surface to find abnormalities that can be predictive of ventricular arrhythmias. METHODS AND RESULTS: Body-surface potential maps were recorded from 62 anterior and posterior thoracic leads in 22 patients affected by ARVD, 9 with episodes of sustained ventricular tachycardias (VT) and 13 without. Thirty-five healthy subjects were also studied as control subjects. The 62 chest ECGs were simultaneously recorded, digitally converted at a rate of 2000 Hz, and stored on a hard disk of a body-surface mapping computer system. In each subject, the QRST integral map was obtained by calculating at each lead point the algebraic sum of all instantaneous potentials, from the QRS onset to the T-wave end, multiplied by the sampling interval. In most ARVD patients, we observed a larger-than-normal area of negative values on the right anterior thorax. This abnormal pattern could be explained by a delayed repolarization of the right ventricle. Nevertheless, it was not related to the occurrence of VT in our patient population. To detect minor heterogeneities of ventricular repolarization, the principal component analysis was applied to the 62 ST-T waves recorded in each subject. We assumed that a low value of the first or of the first three components (components 1, 2, and 3) indicates a greater-than-normal variety of the ST-T waves, a likely expression of a more complex recovery process. The mean values of the first three components were not significantly different in ARVD patients and control subjects. Nevertheless, considering the two subsets of patients with and without VT, the values of component 1, components 1 + 2, and component 1 + 2 + 3 were significantly lower in the group of ARVD patients with VT. Values of component 1 < 69% (equal to 1 SD below the mean value for control subjects) were found in 6 of 9 VT patients and in 1 patient without VT (sensitivity, 67%; specificity, 92%). A low value of component 1 was the only variable significantly associated with the occurrence of VT. CONCLUSIONS: Principal component analysis provides a better quantitative assessment of the complexity of repolarization than other ECG measurements. When applied to ARVD patients, principal component analysis of the ST-T waves recorded from the entire chest surface revealed abnormalities not detected by conventional ECG that can be considered indexes of arrhythmia vulnerability.


Subject(s)
Arrhythmogenic Right Ventricular Dysplasia/physiopathology , Ventricular Function , Adolescent , Adult , Aged , Arrhythmogenic Right Ventricular Dysplasia/complications , Body Surface Potential Mapping , Electrocardiography/methods , Electrophysiology , Female , Humans , Male , Middle Aged , Reference Values , Tachycardia, Ventricular/etiology , Ventricular Function/physiology
5.
Eur Heart J ; 11(11): 997-1005, 1990 Nov.
Article in English | MEDLINE | ID: mdl-2282930

ABSTRACT

The effect of propranolol administration on regional coronary haemodynamics were investigated in 14 patients with stable exertional angina and isolated left anterior descending artery disease. Thermodilution was used to measure great cardiac vein flow (GCVF) and anterior regional coronary resistance (ARCR) under control conditions, at peak atrial pacing, after i.v. propranolol administration (0.1 mg kg-1) and at the peak of repeated atrial pacing. Propranolol did not change peak pacing heart rate, systolic blood pressure or double product. Peak pacing GCVF decreased slightly but non-significantly after drug administration from 84 +/- 20 to 79 +/- 24 ml min-1, while ARCR increased, but again non-significantly, from 1.36 +/- 0.44 to 1.45 +/- 0.45. Analysis of individual patient responses revealed that propranolol prolonged peak pacing time and hence peak pacing heart rate (from 126 +/- 24 to 140 +/- 23 beats min-1, P less than 0.05) in five patients. In such patients, peak pacing systolic blood pressure was lower than the pre-propranolol atrial pacing (145 +/- 35 vs 165 +/- 33, P less than 0.001) so that double product remained unchanged. Moreover, peak pacing ARCR did not change after propranolol (pre-propranolol 1.47 +/- 0.46, after propranolol 1.40 +/- 0.56 mmHg.ml-1.min, P = ns) while it increased significantly in the nine patients who did not improve after the drug (before propranolol 1.30 +/- 0.44, after propranolol 1.48 +/- 0.41 mmHg.ml-1.min, P less than 0.02). These data suggest that the response to atrial pacing after i.v. propranolol administration is variable as some patients tolerate higher heart rates while others do not.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Angina Pectoris/physiopathology , Coronary Circulation/drug effects , Hemodynamics/drug effects , Propranolol/pharmacology , Aged , Angina Pectoris/drug therapy , Cardiac Pacing, Artificial , Coronary Disease/drug therapy , Coronary Disease/physiopathology , Female , Heart Rate/drug effects , Humans , Infusions, Intravenous , Male , Middle Aged , Oxygen Consumption/drug effects , Propranolol/administration & dosage , Propranolol/therapeutic use , Stroke Volume/drug effects , Thermodilution
6.
G Ital Cardiol ; 20(2): 114-22, 1990 Feb.
Article in Italian | MEDLINE | ID: mdl-2328864

ABSTRACT

Primary pulmonary hypertension is an uncommon but serious disease that often results in debilitating symptoms and early death. One approach to treatment has been to attempt a reduction of pulmonary artery pressure and vascular resistance by using vasodilator drugs with conflicting results in several studies. The aim of this study is to review the ten-years (1978-1988) experience of vasodilator therapy for primary pulmonary hypertension at our institute. In this period 7 patients, 5 women and 2 men, mean age 38.4 years (range 15-66) met clinical and hemodynamic criteria for primary pulmonary hypertension. At diagnosis 3/7 patients were in NYHA class III and 2/7 in class II. Diagnosis was confirmed by open lung biopsy in one case. Mean pulmonary artery pressure was 66 +/- 17 mmHg, mean value of pulmonary vascular resistances was 22.5 +/- 11 U.W. and of cardiac index 1.8 +/- 0.58 l/min/m2. Twelve different vasodilator drugs were tested during right heart catheterization in a non randomized manner. Various vasodilators were usually tested in the same patient (2 or more drugs in 6 patients). Only one patient did not tolerate acute therapy because of development of a persistent systemic hypotension. Hemodynamic responses to nitrates showed a general reduction in pulmonary artery pressure and pulmonary vascular resistances with marginal changes in cardiac index. Calcium channel-blocking agents elicited different responses in similar patients with favorable, little, no or adverse effects in pulmonary hemodynamics and sometimes a significant decrease in systemic vascular resistances. Also hydralazine showed favorable hemodynamic results in few cases but exacerbated pulmonary hypertension in others.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Hypertension, Pulmonary/drug therapy , Vasodilator Agents/therapeutic use , Adolescent , Adult , Aged , Biopsy , Blood Pressure/drug effects , Calcium Channel Blockers/therapeutic use , Drug Evaluation , Female , Hemodynamics/drug effects , Humans , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/physiopathology , Lung/pathology , Male , Middle Aged , Nifedipine/therapeutic use , Prognosis , Vasodilator Agents/pharmacology
7.
Circulation ; 73(6): 1248-53, 1986 Jun.
Article in English | MEDLINE | ID: mdl-3698256

ABSTRACT

To investigate the mechanism of the antianginal action of diltiazem in stress-induced myocardial ischemia, we studied 12 patients with stable exertional angina and disease of the proximal left anterior descending artery by measuring great cardiac vein flow (GVCF) and calculating anterior regional coronary resistance (ARCR) during myocardial ischemia induced by atrial pacing before and after intravenous administration of diltiazem (0.25 mg/kg in a bolus dose followed by continuous infusion of 0.005 mg/kg/min). Diltiazem increased the pacing time to angina from 6.9 +/- 3.5 to 10.7 +/- 4 min (p less than .001). At peak pacing heart rate was increased after diltiazem (from 128 +/- 17 to 145 +/- 17 beats/min, p less than .005), while mean arterial pressure was decreased (from 131 +/- 19 to 113 +/- 17 mm Hg, p less than .025), leaving the double product unaltered. At peak pacing no changes were observed in GCVF (from 115 +/- 46 to 119 +/- 46 ml/min, p = NS), ARCR (from 1.3 +/- 0.4 to 1.1 +/- 0.4 mm Hg/ml/min), or myocardial oxygen consumption of the anterior region (from 14.5 +/- 4.2 to 13.4 +/- 4.7 ml/min). Reduction of myocardial oxygen demand plays a major role in the antianginal action of diltiazem in patients with stress-induced myocardial ischemia.


Subject(s)
Angina Pectoris/physiopathology , Benzazepines/pharmacology , Cardiac Pacing, Artificial , Coronary Disease/physiopathology , Diltiazem/pharmacology , Adult , Angina Pectoris/diagnostic imaging , Angina Pectoris/metabolism , Cardiac Catheterization , Coronary Disease/diagnostic imaging , Coronary Disease/metabolism , Diltiazem/therapeutic use , Exercise Test , Female , Heart Atria/physiopathology , Hemodynamics/drug effects , Humans , Male , Middle Aged , Myocardium/metabolism , Oxygen Consumption/drug effects , Radiography , Rest
SELECTION OF CITATIONS
SEARCH DETAIL
...